Skip to content

The effect of traditional Chinese medicine prescription Gushen Antai Pill on the treatment outcome of hormone replacement cycle FETs: a multicenter, double-blind, randomized, placebo-controlled trial

Study for the theory of kidney dominating reproduction based on the whole regulatory network of differential protein metabolites in IVF follicular fluid

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026737
Enrollment
Unknown
Registered
2019-10-20
Start date
2019-10-20
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

FET's infertile women

Interventions

Sponsors

Integrative Medicine Research Centre of Reproduction and Heredity, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged 18-40 years; 2. there are two or more high-quality transplantable frozen foetuses; 3. the patients who have received FET in hormone replacement cycle; 4. the past FET history is less than 3 times, the history of abortion is less than 2 times, the history of implant failure is less than 2 times; 5. the patients who have not applied similar drug treatment history, no history of mental illness, no abnormality in liver and kidney function and ECG, and normal chromosome karyotype; 6. the patients agree to the experimental study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. BMI >= 30kg / m2; 2. reproductive system development abnormality, chromosome karyotype abnormality of both men and women; 3. patients with major systemic diseases; 4. patients with endometriosis, adenomyosis, hydrosalpinx; 5. patients with endometrial disease; 6. patients with recurrent abortion and repeated planting failure.

Design outcomes

Primary

MeasureTime frame
Persistent pregnancy rate;Incidence of threatened abortion;clinical pregnancy rate;

Countries

China

Contacts

Public ContactZhengao Sun

Integrative Medicine Research Centre of Reproduction and Heredity, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine

sunzhengao77@126.com+86 13708938621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026